Evidence map›Paper›PMID 25986070›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2015

Glycemic control rate of T2DM outpatients in China: a multi-center survey.

Rong Chen, Linong Ji, Liming Chen, Li Chen, Dehong Cai, Bo Feng, Hongyu Kuang, Hong Li, Yiming Li, Jing Liu and 10 more

Open access · hybridAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Rong ChenDepartment of Endocrinology, Changhai Hospital of Second Military Medical University of Chinese PLA, Shanghai, China (mainland).
Linong JiDepartment of Endocrinology, Peking University People's Hospital, Beijing, China (mainland).
Liming ChenDepartment of Metabolic Disease, Tianjin Medical University, Tianjin, China (mainland).
Li ChenDepartment of Endocrinology, Qilu Hospital of Shandong University, Jinan, Shandong, China (mainland).
Dehong CaiDepartment of Endocrinology, Zhujiang Hospital of First Military Medical University, Guangzhou, Guangdong, China (mainland).
Bo FengDepartment of Endocrinology, Shanghai East Hospital, Shanghai, China (mainland).
Hongyu KuangDepartment of Endocrinology, Harbin Medical University, Harbin, Heilongjiang, China (mainland).
Hong LiDepartment of Endocrinology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China (mainland).
Yiming LiDepartment of Endocrinology, Huashan Hospital of Fudan University, Shanghai, China (mainland).
Jing LiuDepartment of Endocrinology, Gansu Provincial Hospital, Lanzhou, Gansu, China (mainland).
Zhongyan ShanDepartment of Endocrinology, First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China (mainland).
Zilin SunDepartment of Endocrinology, Zhongda Hospital Southeast University, Nanjing, Jiangsu, China (mainland).
Haoming TianDepartment of Endocrinology, West China Hospital, Sichuan University, Chengdu, Sichuan, China (mainland).
Zhangrong XuDepartment of Endocrinology, The 306th Hospital of PLA, Beijing, China (mainland).
Yancheng XuDepartment of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China (mainland).
Yuzhi YangDepartment of Endocrinology, Heilongjiang Provincial Hospital, Harbin, Heilongjiang, China (mainland).
Liyong YangDepartment of Endocrinology, First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China (mainland).
Xuefeng YuDepartment of Endocrinology, Tongji Hospital, Wuhan, Hubei, China (mainland).
Dalong ZhuDepartment of Endocrinology, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China (mainland).
Dajin ZouDepartment of Endocrinology, Changhai Hospital of Second Military Medical University of Chinese PLA, Shanghai, China (mainland).
Second Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundType 2 diabetes mellitus (T2DM)-associated mortality and morbidity are strongly dependent on glycemic control. With T2DM prevalence increasing in China, we aimed to assess glycemic control rates in Chinese T2DM outpatients. MATERIAL/

methodsA total of 9065 adult T2DM outpatients (5035 men) were assessed in 26 Chinese medical centers between August 2010 and April 2012. Patients were stratified according to BMI (kg/m2): <24, 24-28, and >28. Successful glycemic control was defined as glycated hemoglobin A1c (HbA1c) ≤7% or fasting plasma glucose (FPG) <7.0 mmol/L.

resultsAmong the participants included in this study, 2939 had BMI <24, 3361 had BMI of 24-28, and 2764 had BMI >28. The glycemic control rate was only 32.6%, and the triple control rate for glycemia, blood pressure, and lipidemia was only 11.2%. Glycemic control rates by BMI group were 33.7% (<24), 33.8% (24-28), and 30.2% (>28) (p=0.005), and corresponding incidences of cardiovascular diseases (CVD) were 12.2%, 15.7%, and 15.9% (p<0.001). Multivariate logistic regression analysis demonstrated that older age (p<0.001), higher BMI (p=0.026), larger waist circumference (p<0.001), less education (p<0.001), and recent diagnosis (p<0.001) were independent risk factors for poor glycemic control.

conclusionsThe T2DM glycemic control rate in China is currently low, especially in older obese patients with poor education and recent diagnosis.

Indexed as

AdultAgedAge FactorsAnthropometryBlood GlucoseBody Mass IndexCardiovascular DiseasesChinaComorbidityDiabetes ComplicationsDiabetes Mellitus, Type 2Drug MonitoringEducational StatusFemaleGlycated HemoglobinHumansBlood GlucoseGlycated HemoglobinLipids

Identifiers

PMID25986070
PMCPMC4448594
OpenAlexW2220990852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.